Urinary Bladder Cancer, Muscle-invasive
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB13007 | Enfortumab vedotin | 3 | Recruiting | 1 |
| DB09037 | Pembrolizumab | 3 | Recruiting | 1 |
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB13007 | Enfortumab vedotin | 3 | Recruiting | 1 |
| DB09037 | Pembrolizumab | 3 | Recruiting | 1 |